Skip to content

Application of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive Performance

Application of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive Performance

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03112902
Enrollment
24
Registered
2017-04-13
Start date
2018-03-07
Completion date
2021-05-04
Last updated
2021-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Brief summary

Loss of slow wave sleep (SWS) is common in mild cognitive impairment (MCI) and Alzheimer's disease, and is thought to worsen thinking, memory and brain degeneration. Initial studies suggest that correction of sleep deterioration may slow the progression of brain damage in mild cognitive impairment, and might be able to stop the development of Alzheimer's disease. Transcranial alternating current stimulation (tACS) uses electrodes to deliver very small amounts of electricity through the brain, with direct effects on brain cell function. Transcranial electric stimulation has been demonstrated to enhance slow wave sleep and to improve memory when applied during sleep in healthy adults. The purpose of this research is to investigate tACS to modulate sleep, thinking/memory, mood, and quality of life among normal healthy adults, older adults, as well as individuals with MCI.

Interventions

DEVICEApplication of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive Performance

Transcranial Alternating Current Stimulation will be applied during slow wave sleep to assess effects on memory and sleep architecture.

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Ages 18-85 * Native English speakers * Neurological diagnosis of amnestic mild cognitive impairment (aMCI)

Exclusion criteria

* brain tumors * skull defects * epilepsy * metal implants/devices above the neck * eczema or sensitive skin * insomnia * sleep apnea that requires use of a CPAP machine * rapid eye movement (REM)-sleep behavior disorder * currently pregnant or trying to become pregnant during the study period * diagnosis of cognitive impairment \*cognitive impairment required for MCI arms

Design outcomes

Primary

MeasureTime frameDescription
Change in Electro-encephalogram (EEG) Power of Slow Wave OscillationsBefore and after each night of study session, up to 24 weeks from enrollment for each subjectPower of EEG data in microvolts within slow wave frequency range.

Secondary

MeasureTime frameDescription
Change in Procedural Memory Encoding *No Processing of Data Occurred to Provide Information About This Outcome Measure.Before and after each night of study session, up to 24 weeks from enrollment for each subjectFinger tapping task \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure
Change in Sleep Architecture as Measured by Minutes in Each Stage of Sleep *No Processing of Data Occurred to Provide Information About This Outcome Measure.Before and after each night of study session, up to 24 weeks from enrollment for each subjectEEG data \*No processing of data occurred to provide information about this outcome measure.
Change in Fast and Slow Spindle Numbers During Sleep *No Processing of Data Occurred to Provide Information About This Outcome Measure.Before and after each night of study session, up to 24 weeks from enrollment for each subjectEEG data \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure
Change in Slow Wave Coherence *No Processing of Data Occurred to Provide Information About This Outcome Measure.Before and after each night of study session, up to 24 weeks from enrollment for each subjectEEG data \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure
Change in Slow Wave Power *No Processing of Data Occurred to Provide Information About This Outcome Measure.Before and after each night of study session, up to 24 weeks from enrollment for each subjectEEG data \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure
Change in Declarative Memory EncodingBefore and after each night of study session, up to 24 weeks from enrollment for each subject.Word-paired associations
Change in Hospital Anxiety and Depression Scale (HADS) *No Processing of Data Occurred to Provide Information About This Outcome Measure.Before and after each night of study session, up to 24 weeks from enrollment for each subjectMood outcome \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure
Change in Clinical Global Impression of Change (CGIC) *No Processing of Data Occurred to Provide Information About This Outcome Measure.Before and after each night of study session, up to 24 weeks from enrollment for each subjectGlobal assessment \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure
Change in Battery of Working Memory Tasks *No Processing of Data Occurred to Provide Information About This Outcome Measure.Before and after each night of study session, up to 24 weeks from enrollment for each subjectAssessment of working memory \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure
Change in Battery of Attention Tasks *No Processing of Data Occurred to Provide Information About This Outcome Measure.Before and after each night of study session, up to 24 weeks from enrollment for each subjectAssessment of attention \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure
Change in Battery of Visuospatial Processing Tasks *No Processing of Data Occurred to Provide Information About This Outcome Measure.Before and after each night of study session, up to 24 weeks from enrollment for each subjectAssessment of visuospatial ability \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure
Change in Sleep Architecture as Measured by Self Reported Sleep Timing *No Processing of Data Occurred to Provide Information About This Outcome Measure.Before and after each night of study session, up to 24 weeks from enrollment for each subjectSleep diary for subjective experience \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure

Countries

United States

Participant flow

Participants by arm

ArmCount
Effects of tACS During SWS- Standard/Nested 1
Application of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive Performance: Transcranial Alternating Current Stimulation will be applied during slow wave sleep to assess effects on memory and sleep architecture. This is a triple crossover: standard tACS, then nested tACS, then sham.
2
Effects of tACS During SWS- Standard/Nested 2
This is a triple crossover: nested tACS, then standard tACS, then sham.
2
Effects of tACS During SWS- Standard/Nested 3
This is a triple crossover: sham, then nested tACS, then standard tACS.
3
Effects of tACS During SWS- Standard/Nested 4
This is a triple crossover: sham, then standard tACS, then nested tACS
1
Effects of tACS During SWS- Standard/Nested 5
This is a triple crossover: nested tACS, then sham, then standard tACS
1
Effects of tACS During SWS- Standard/Nested 6
This is a triple crossover: nested tACS, then standard tACS, then sham.
3
Effects of tACS During SWS- Older Adults Active 1
Application of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive Performance: Transcranial Alternating Current Stimulation will be applied during slow wave sleep to assess effects on memory and sleep architecture. This is a crossover: standard tACS, then sham.
9
Effects of tACS During SWS- Older Adults Active 2
This is a crossover: sham, then tACS.
3
Effects of tACS During SWS- MCI Active 1
Application of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive Performance: Transcranial Alternating Current Stimulation will be applied during slow wave sleep to assess effects on memory and sleep architecture. This is a crossover: standard tACS, then sham.
0
Effects of tACS During SWS- MCI Active 2
This is a crossover: sham, then tACS.
0
Total24

Baseline characteristics

CharacteristicEffects of tACS During SWS- MCI Active 1TotalEffects of tACS During SWS- Standard/Nested 2Effects of tACS During SWS- Standard/Nested 3Effects of tACS During SWS- Standard/Nested 4Effects of tACS During SWS- Standard/Nested 5Effects of tACS During SWS- Standard/Nested 6Effects of tACS During SWS- Older Adults Active 1Effects of tACS During SWS- Older Adults Active 2Effects of tACS During SWS- Standard/Nested 1Effects of tACS During SWS- MCI Active 2
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants7 Participants0 Participants0 Participants0 Participants0 Participants0 Participants5 Participants2 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants17 Participants2 Participants3 Participants1 Participants1 Participants3 Participants4 Participants1 Participants2 Participants0 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants23 Participants2 Participants3 Participants1 Participants1 Participants2 Participants9 Participants3 Participants2 Participants0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants0 Participants0 Participants0 Participants0 Participants1 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants2 Participants0 Participants0 Participants0 Participants0 Participants0 Participants1 Participants1 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants22 Participants2 Participants3 Participants1 Participants1 Participants3 Participants8 Participants2 Participants2 Participants0 Participants
Region of Enrollment
United States
24 participants2 participants3 participants1 participants1 participants3 participants9 participants3 participants2 participants
Sex: Female, Male
Female
0 Participants12 Participants0 Participants0 Participants1 Participants1 Participants2 Participants4 Participants2 Participants2 Participants0 Participants
Sex: Female, Male
Male
0 Participants12 Participants2 Participants3 Participants0 Participants0 Participants1 Participants5 Participants1 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
EG005
affected / at risk
EG006
affected / at risk
EG007
affected / at risk
EG008
affected / at risk
EG009
affected / at risk
deaths
Total, all-cause mortality
0 / 20 / 20 / 30 / 10 / 10 / 30 / 90 / 10 / 00 / 0
other
Total, other adverse events
0 / 20 / 20 / 30 / 10 / 10 / 30 / 90 / 30 / 00 / 0
serious
Total, serious adverse events
0 / 20 / 20 / 30 / 10 / 10 / 30 / 90 / 30 / 00 / 0

Outcome results

Primary

Change in Electro-encephalogram (EEG) Power of Slow Wave Oscillations

Power of EEG data in microvolts within slow wave frequency range.

Time frame: Before and after each night of study session, up to 24 weeks from enrollment for each subject

Population: Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure

Secondary

Change in Battery of Attention Tasks *No Processing of Data Occurred to Provide Information About This Outcome Measure.

Assessment of attention \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure

Time frame: Before and after each night of study session, up to 24 weeks from enrollment for each subject

Population: Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for the study outcome measures.

Secondary

Change in Battery of Visuospatial Processing Tasks *No Processing of Data Occurred to Provide Information About This Outcome Measure.

Assessment of visuospatial ability \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure

Time frame: Before and after each night of study session, up to 24 weeks from enrollment for each subject

Population: Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for the study outcome measures.

Secondary

Change in Battery of Working Memory Tasks *No Processing of Data Occurred to Provide Information About This Outcome Measure.

Assessment of working memory \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure

Time frame: Before and after each night of study session, up to 24 weeks from enrollment for each subject

Population: Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for the study outcome measures.

Secondary

Change in Clinical Global Impression of Change (CGIC) *No Processing of Data Occurred to Provide Information About This Outcome Measure.

Global assessment \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure

Time frame: Before and after each night of study session, up to 24 weeks from enrollment for each subject

Population: Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for the study outcome measures.

Secondary

Change in Declarative Memory Encoding

Word-paired associations

Time frame: Before and after each night of study session, up to 24 weeks from enrollment for each subject.

Population: Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for the study outcome measures.

Secondary

Change in Fast and Slow Spindle Numbers During Sleep *No Processing of Data Occurred to Provide Information About This Outcome Measure.

EEG data \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure

Time frame: Before and after each night of study session, up to 24 weeks from enrollment for each subject

Population: Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for the study outcome measures.

Secondary

Change in Hospital Anxiety and Depression Scale (HADS) *No Processing of Data Occurred to Provide Information About This Outcome Measure.

Mood outcome \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure

Time frame: Before and after each night of study session, up to 24 weeks from enrollment for each subject

Population: Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for the study outcome measures.

Secondary

Change in Procedural Memory Encoding *No Processing of Data Occurred to Provide Information About This Outcome Measure.

Finger tapping task \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure

Time frame: Before and after each night of study session, up to 24 weeks from enrollment for each subject

Population: Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for the study outcome measures.

Secondary

Change in Sleep Architecture as Measured by Minutes in Each Stage of Sleep *No Processing of Data Occurred to Provide Information About This Outcome Measure.

EEG data \*No processing of data occurred to provide information about this outcome measure.

Time frame: Before and after each night of study session, up to 24 weeks from enrollment for each subject

Population: Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for the study outcome measures.

Secondary

Change in Sleep Architecture as Measured by Self Reported Sleep Timing *No Processing of Data Occurred to Provide Information About This Outcome Measure.

Sleep diary for subjective experience \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure

Time frame: Before and after each night of study session, up to 24 weeks from enrollment for each subject

Population: Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for the study outcome measures.

Secondary

Change in Slow Wave Coherence *No Processing of Data Occurred to Provide Information About This Outcome Measure.

EEG data \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure

Time frame: Before and after each night of study session, up to 24 weeks from enrollment for each subject

Population: Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for the study outcome measures.

Secondary

Change in Slow Wave Power *No Processing of Data Occurred to Provide Information About This Outcome Measure.

EEG data \*Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for this outcome measure

Time frame: Before and after each night of study session, up to 24 weeks from enrollment for each subject

Population: Problems and new insights related to the study's design were encountered during data collection that fundamentally affected the rationale and feasibility of the trial. Trial was terminated before sufficient data could be collected and analyzed. No data was analyzed for the study outcome measures.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026